Novo Nordisk A/S
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | Reuters Eli Lilly on Wednesday said its highly popular weight loss drug Zepbound showed the potential to treat patients with the most common sleep-related breathing disorder in two late-stage clinical trials. The […]
Read More
These are the top rated 5 companies to get the job done for in India, in accordance to LinkedIn
These are the 2024 best businesses in India, according to LinkedIn. Deepak Sethi | E+ | Getty Photos LinkedIn has unveiled its eighth yearly list of best corporations to work for in India, and corporations that prioritized its employees’ working experience and expansion dominated this year’s ranking. From mass layoffs to the adoption of generative […]
Read More
A prime Nvidia shareholder reveals his set off for marketing advancement shares
Nvidia shares have continued to soar this calendar year, up far more than 80%. But one of its best shareholders has unveiled why they’ve been selling the stock. Jennison Associates, the 15th largest shareholder of Nvidia, was an early investor in the chipmaker and now retains $7 billion worth of shares, or .57% of the […]
Read More
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters European Union drug regulators found no evidence that highly popular weight loss and diabetes drugs such as Wegovy and Ozempic are linked to an increased risk of suicidal thoughts and self-injury, the regulator […]
Read More
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
The coronal view of a human brain of a patient suffering from Parkinson’s disease Sherbrooke Connectivity Imaging Lab | Getty Images A highly popular class of drugs for diabetes and obesity is showing early potential to help patients with Parkinson’s disease, too. An older diabetes treatment called lixisenatide helped slow the progression of motor disability […]
Read More
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Pots of Activia yoghurt, manufactured by Danone SA, sit on display. Bloomberg | Getty Images The CEO of French consumer goods giant Danone downplayed the threat of obesity drugs on its food business, arguing that consumers were likely to turn to healthy products as part of their new weight loss regime. Antoine de Saint-Affrique said […]
Read More
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Drugmakers spent big on advertisements for weight loss and diabetes treatments last year […]
Read More
Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage trial, a finding that could set it apart in a potentially crowded market. Altimmune is one of several smaller biotech companies that are pushing to compete directly with Novo Nordisk and Eli Lilly […]
Read More
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | Reuters The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close to $1,000 per month for the injection in the U.S. before insurance, a […]
Read More
Viking Therapeutics stock jumps more than 15% on promising weight loss pill data
Alexey Krukovsky | Istock | Getty Images Viking Therapeutics shares jumped more than 15% on Tuesday after the company said its experimental weight loss pill showed positive results in a small study and will enter the next stage of development later this year. The study results add to the excitement around the drugmaker’s prospects in […]
Read More